-

Redwire Corporation to Report Second Quarter 2026 Results on August 5, 2026

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW; “Redwire” or “the Company”) today announced that it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 5, 2026.

Management will also conduct a conference call starting at 9 a.m. ET on Thursday, August 6, 2026, to review financial results for the second quarter 2026. The earnings conference call can be accessed by calling 877-485-3108 (toll free) or 201-689-8264 (toll), and the conference ID is 13761352.

A presentation with slides will also be live streamed. Please click the link below to follow along with the live stream: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ITIRLOWy

The listen-only audio webcast of the call will be available in the investor relations area of the company’s website at https://ir.rdw.com. Please call in or log on at least five minutes in advance of the scheduled start time.

For those who are unable to listen to the live event, a replay will be available for two weeks following the event by dialing 877-660-6853 (toll-free) or 201-612-7415 (toll) and entering the access code 13761352. To access the webcast replay, visit the investor relations area of the company’s website at https://ir.rdw.com/.

The earnings release and other information related to the earnings announcement will be available on RDW.com.

About Redwire

Redwire Corporation (NYSE:RDW) is an integrated space and defense tech company focused on advanced technologies. We are building the future of aerospace infrastructure, autonomous systems, and multi-domain operations leveraging digital engineering and AI automation. Redwire’s approximately 1,400 employees located throughout North America and Europe are committed to delivering innovative space and airborne platforms transforming the future of multi-domain operations. For more information, please visit RDW.com.

Contacts

Investors:
investorrelations@rdw.com

Industry:

Redwire Corporation

NYSE:RDW
Release Versions
English
$Cashtags
$RDW

Contacts

Investors:
investorrelations@rdw.com

More News From Redwire Corporation

Redwire’s SpaceMD Announces its First Commercial Mission on SpaceX’s Starfall Spacecraft to Scale In-Space Pharmaceutical Development

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Space Microgravity Development LLC (SpaceMD), a wholly owned subsidiary of Redwire Corporation (NYSE:RDW) and venture company focused on leveraging the microgravity environment to create dynamic innovations, announced today that it has signed a contract for a Starfall mission. Starfall is SpaceX’s new spacecraft that enables affordable, routine access to a microgravity environment and provides unique opportunities for on-orbit manufacturing, scientific resea...

Redwire Corporation Reports Second Quarter 2026 Financial Results, Achieves Record Revenue, Gross Margins, and Contracted Backlog

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE:RDW, “Redwire” or the “Company”), a global leader in space and defense technology solutions, today announced results for its second quarter ended June 30, 2026. “With new record highs for both revenue of $117.1 million and gross margin of 27.8%, Redwire’s second quarter of 2026 was defined by successful execution,” said Peter Cannito, Chairman, Chief Executive Officer, and President of Redwire. “With a record Backlog1 of $542.1 mill...

Redwire Opens State-of-the-Art Facility in Indiana to Accelerate Space-Enabled R&D and Manufacturing with a Focus on Next-Gen Drug Development and Human Health Breakthroughs

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, has opened its new 30,000 square foot state-of-the-art, vertically-integrated research and microgravity payload development facility in Georgetown, Indiana. The facility will serve as a global hub supporting accelerated demand as the company continues to expand its leadership in space-enabled research, development, and manufacturing with a focus on pharmaceutical/biot...
Back to Newsroom